Erowid.org: Erowid Reference 41 : Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine? : Lauerma H, Wuorela M, Halme M

Erowid References Database

Lauerma H, Wuorela M, Halme M. “Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine?”. Biol Psychiatry. 1998 Jun 15;43(12):929. <a name="ref">Lauerma H, Wuorela M, Halme M.</a> <a href="/references/41">"Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine?"</a> <i>Biol Psychiatry</i>. 1998 Jun 15;43(12):929.
Text Abstract (this page) Full Text - English (private) Response To McCann UD (1996) Show Articles by Lauerma H Wuorela M Halme M Article IDs Erowid RefID: 41 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract The increasingly popular illicit drug “ecstasy” or 3,4-methylenedioxymethamphtamine (MDMA), has been associated with malignant neroleptic syndrome, irreversible brain damage and psychiatric morbidity. Users tend to consider it a safe recreational drug. Its major mechanism is serotonergic. No reports concerning interaction of MDMA and selective serotonin reuptake inhibitors in humans were found in Medline.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]